According to filings with the U.S. Securities and Exchange Commission, Excision Medical is raising up to $3,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Greg Walters played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Excision Medical
The Excision Medical Leaflet Excision System is designed to allow physicians to target and excise one or more aortic valve leaflets while also considering the hemodynamic needs of patients. Leaflet removal (or excision) will be key to properly mitigating the risk of coronary artery ostia obstruction, and debulking the existing valve prior to the redo TAVR, which may also offer additional benefits to the performance of the new valve. Excision Medical is setting the stage for fast and effective valve replacement by designing the system to integrate into the workflow of TAVR procedures as the wave of secondary replacement approaches in the coming years. Leaflet Excision is the natural evolution of TAVR.

To learn more about Excision Medical, visit http://excisionmed.com/

Contact:
Greg Walters, President and Chief Executive Officer
610-334-6091
https://www.linkedin.com/in/greg-walters-7b5a2917/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.